A single challenge in vaccine development is economic: Most of the illnesses most demanding a vaccine, which include HIV, malaria and tuberculosis, exist principally in bad nations around the world. Pharmaceutical companies and biotechnology firms have small incentive to create vaccines for these disorders because there is minimal revenue potential